Medication info
CMG Pitavastatin Tablet 2mg (Pitavastatin Calcium Hydrate)

CMG Pitavastatin Tablet 2mg (Pitavastatin Calcium Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Pitavastatin Calcium Hydrate›2mg / 1 tablet
Manufacturer / importer
CMG Pharmaceutical Co., Ltd.
Appearance
Very pale yellowish-red round film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201405925 · Approved 2014.12.17 · Insurance code 648602920

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
Before and during treatment with this medicine, patients must follow a standard cholesterol-lowering diet. The usual initial adult dose is 1~2 milligrams of pitavastatin calcium per dose once daily. If the reduction in LDL cholesterol is inadequate, the dose may be increased to a maximum of 4 milligrams daily. Depending on LDL cholesterol levels, treatment goals, and the patient's response, the dose may be adjusted at intervals of 4 weeks or longer. The therapeutic effect of this medicine is maintained with continued use.

Ingredients

Manufacturer
CMG Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • elevated LDL-cholesterol
  • elevated apolipoprotein B
  • elevated triglyceride levels
View approved original text

This medication helps improve blood lipid levels in patients with primary hypercholesterolemia and mixed dyslipidemia. It particularly lowers levels of total cholesterol, LDL-cholesterol, apolipoprotein B, and triglycerides while raising levels of HDL-cholesterol, the 'good' cholesterol. This medication is used alongside dietary measures to effectively manage blood lipid imbalances, contributing to a reduction in cardiovascular disease risk with consistent use, thus playing a crucial role in the treatment of hypercholesterolemia and dyslipidemia.

How to take

Adult dose

Before and during treatment with this medicine, patients must follow a standard cholesterol-lowering diet. The usual initial adult dose is 1~2 milligrams of pitavastatin calcium per dose once daily. If the reduction in LDL cholesterol is inadequate, the dose may be increased to a maximum of 4 milligrams daily. Depending on LDL cholesterol levels, treatment goals, and the patient's response, the dose may be adjusted at intervals of 4 weeks or longer. The therapeutic effect of this medicine is maintained with continued use.

Precautions

This medication should not be administered to certain patients. For example, patients with allergies to this medication or with active liver disease, severe liver impairment, or bile duct obstruction, patients taking cyclosporine, those with myopathy, pregnant or potentially pregnant women, nursing mothers, and pediatric patients should not use this medication. Additionally, patients with impaired kidney function or a history of liver disease, individuals who excessively consume alcohol, and those on fibric acid derivatives or niacin, patients with hypothyroidism, elderly individuals, etc., should use this medication with caution. While taking this medication, various side effects such as muscle pain, fatigue, liver function abnormalities, skin rashes, and blood abnormalities may occur, so if any symptoms appear, medical consultation should be sought immediately. Notably, muscle-related symptoms may progress to a serious condition called rhabdomyolysis, necessitating vigilance. Since this medication is primarily metabolized in the liver, regular liver function tests should be conducted, and administration should be stopped if abnormalities are found. Also, patients with a risk of diabetes should periodically check their blood glucose levels. When taking this medication with other drugs, interactions may occur, especially if co-administered with cyclosporine, fibric acid derivatives, niacin, erythromycin, etc. If symptoms appear during co-administration with these drugs, administration should be halted immediately due to potential muscle damage or worsening kidney function. Elderly patients should exercise greater caution as the risk of adverse reactions is higher. Pregnant or nursing women should not take this medication as it may pose risks to the fetus or newborn. If pregnancy is confirmed, administration should be stopped immediately. The safety and efficacy of this medication in pediatric patients have not been established, hence it should not be used in children. Finally, this medication should be kept out of the reach of children and stored in its original container to prevent misuse and preserve its quality.

Side effects

  • Abdominal pain
  • rash
  • malaise
  • paralysis
  • itching
  • myalgia
  • weakness
  • increased CPK levels
  • elevated myoglobin in blood and urine
  • liver dysfunction
Show 89 more
  • jaundice
  • thrombocytopenia
  • urticaria
  • erythema
  • angioedema
  • elevated bilirubin
  • increased cholinesterase
  • elevated AST
  • elevated ALT
  • elevated γ-GT
  • elevated ALP
  • elevated LDH
  • stiffness
  • drowsiness
  • insomnia
  • headache
  • heaviness in the head
  • dizziness
  • thirst
  • dyspepsia
  • abdominal bloating
  • constipation
  • stomatitis
  • vomiting
  • loss of appetite
  • glossitis
  • nausea
  • gastric discomfort
  • diarrhea
  • neutropenia
  • leukopenia
  • eosinophilia
  • leukocytosis
  • elevated globulin
  • positive Coombs test
  • anemia
  • increased frequency of urination
  • elevated BUN
  • increased serum creatinine
  • decreased aldosterone
  • increased aldosterone
  • elevated adrenocorticotropic hormone
  • increased cortisol
  • decreased testosterone
  • muscle cramps
  • weakness
  • palpitations
  • fatigue
  • skin pain
  • burning sensation
  • arthralgia
  • swelling
  • blurred vision
  • photophobia
  • hearing loss
  • hematuria
  • increased uric acid levels
  • elevated serum potassium and phosphorus
  • altered taste
  • malaise
  • positive antinuclear antibody
  • sleep disorder
  • memory loss
  • depression
  • interstitial lung disease
  • sexual dysfunction
  • diabetes
  • immune-mediated necrotizing myopathy
  • myasthenia gravis
  • ocular myasthenia
  • facial swelling
  • arm swelling
  • hypersensitivity
  • headache
  • dizziness
  • skin tingling
  • insomnia
  • loss of appetite
  • increased blood pressure
  • chest discomfort
  • weakness
  • abdominal pain
  • thirst
  • nausea
  • thrombocytopenia
  • increased serum creatinine
  • increased BUN
  • skin tingling
  • chest discomfort

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a container that does not allow light to enter. Additionally, it is important to maintain room temperature, between 1 degree and 30 degrees Celsius, while storing the medication. Doing so ensures the medication's effectiveness and safety for use.

Appearance and packaging

Appearance

Very pale yellowish-red round film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.